期刊文献+

2型糖尿病患者血浆中COX-2与VEGF的变化及其与尿蛋白水平的相关性研究 被引量:1

The Relationship between Plasma COX-2/VEGF and Albuminuria in Type 2 Diabetic Patients
原文传递
导出
摘要 目的通过检测糖尿病患者血浆中环氧化酶同工酶-2(COX-2)与血管内皮生长因子(VEGF)的变化,了解COX-2及VEGF水平的变化及其与患者尿蛋白定量之间的关系。方法收入51例2型糖尿病患者及47例年龄/性别匹配的健康志愿者,以ELISA法检测其血浆中COX-2与VEGF的水平,同时对研究对象的尿蛋白水平等肾功能指标进行检测,并对两组指标进行相关性分析。结果糖尿病患者血浆COX-2水平(55.58±8.84)ng/mL及VEGF水平(377.59±38.60)pg/mL均显著高于对照组[COX-2(0.89±0.27)ng/mL,VEGF(43.51±8.61)pg/mL](P均<0.01);COX-2与VEGF之间存在正相关,差异有统计学意义(r=0.983,P<0.01),COX-2及VEGF与患者尿蛋白之间均存在正相关,差异有统计学意义(COX-2与尿蛋白r=0.728,P<0.01;VEGF与尿蛋白r=0.769,P<0.01);COX-2及VEGF与患者血肌酐之间均存在正相关,差异有统计学意义(COX-2与血肌酐r=0.649,P<0.01;VEGF与血肌酐r=0.619,P<0.01)。结论2型糖尿病患者血浆中存在明显升高的COX-2及VEGF,并与患者尿蛋白水平及血肌酐水平存在相关性,提示COX-2及VEGF可能参与糖尿病肾病的发病过程。 Objective This study aims to understand the correlation between the changes of cyclo-oxygenase-2 (COX-2), vascular endothelial growth factor (VEGF) and urinary albumin in type 2 diabetic patients. Methods 51 type 2 diabetic patients and 47 normal control subjects with similar age and gender were enrolled into the study. The plasma level of COX-2 and VEGF was detected by ELISA. The levels of urinary albumin and renal functions were also examined. Results The level of plasma COX-2 (55.58±8.84) ng/mL and VEGF (377.59±38.60) pg/mL in type 2 diabetic patients was significantly higher than the control subjects [ COX-2 (0.89±0.27) ng/mL, VEGF (43.51±8.61) pg/mL, Both P〈0.01 ]. In diabetic patients, a positive correlation between the level of COX-2 and VEGF was observed (r=0.983,P〈0.01). Both COX-2 and VEGF showed positive correlation with the level of urinary proteins (COX-2 and albumin, r=0.728,P〈0.01; VEGF and albumin, r=0.769,P〈0.01). The levels of COX-2 and VEGF were also positively correlated with the patients' serum creatine level (COX-2 and serum creatine r=0.649,P〈0.01; VEGF and serum creatine r=0.619,P〈0.01 ). Conclusion The levels of plasma COX-2 and VEGF are elevated in type 2 diabetic patients and the levels are positively correlated with urinary albumin and serum creatine. Both COX-2 and VEGF may be involved in the pathogenesis of diabetic nephropathy.
出处 《热带医学杂志》 CAS 2009年第9期1026-1027,1037,共3页 Journal of Tropical Medicine
基金 广东省中医药局科研课题(No.2007230)
关键词 糖尿病 糖尿病肾病 环氧化酶同工酶-2 血管内皮生长因子 diabetes mellitus diabetic nephropathy cyclo-oxygenase-2 vascular endothelial growth factor
  • 相关文献

参考文献8

  • 1Locatelli F, Canaud B, Eckardt KU, et al. The importance of diabetic nephropathy in current nephrological practice [J]. Nephrol Dial Transplant, 2003,18(9) : 1716-1725.
  • 2Fujimura T, Ohta T, Oyama K, et al. Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers [J ]. J Gastrointest Cancer, 2007,38 (2-4) : 78-82.
  • 3Bernard MP, Bancos S, Sime PJ, et al. Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise [ J ]. Curr Pharm Des, 2008,14 (21) : 2051-2060.
  • 4Nishikawa T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications [ J ]. Antioxid Redox Signal, 2007,9 ( 3 ) : 343- 353.
  • 5刘淑霞,张玉军,张景坤,刘青娟,唐丽娟,段惠军.核转录因子κΒ/环氧化酶-2参与糖尿病肾病大鼠肾细胞增殖[J].基础医学与临床,2008,28(9):944-948. 被引量:5
  • 6Yabuki A, Tahara T, Taniguchi K, et al. Neuronal nitric oxide synthase and cyclooxygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats [J]. Exp Anita, 2006,55 (1): 17-25.
  • 7Chen S, Ziyadeh FN. Vascular endothelial growth factor and diabetic nephropathy [ J ]. Curt Diab Rep, 2008,8 (6) : 470- 476.
  • 8Sato W, Kosugi T, Zhang L, et al. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy [J]. Lab Invest, 2008,88 (9) : 949-961.

二级参考文献11

  • 1李英,薛静,汪晶华,张益民,林海英,段惠军.缬沙坦下调糖尿病大鼠肾皮质葡萄糖转运蛋白1和TGFβ_1 mRNA的表达[J].基础医学与临床,2004,24(3):287-290. 被引量:8
  • 2王丽晖,段惠军,史永红,刘青娟,刘淑霞,高峰.磷酸化的cAMP反应元件结合蛋白_1在糖尿病大鼠肾小球中表达增强[J].基础医学与临床,2005,25(3):232-236. 被引量:4
  • 3孙国柱,张庆俊,张更申,李建峰.NF-κB和IκB对兔实验性脊髓空洞前状态神经元凋亡的影响[J].基础医学与临床,2006,26(4):415-419. 被引量:5
  • 4张玉军,刘淑霞,齐凤英,左连富,郭建文.戊地昔布诱导人食管癌Eca109细胞凋亡的机制研究[J].中国药理学通报,2006,22(5):629-633. 被引量:9
  • 5Tak PP, Firestein GS. NF-kappa B: a key role in inflam- matorydiseases [ J ]. J Clin Invest, 2001, 107 ( 1 ) : 7 - 11.
  • 6Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats [ J ]. Kidney Int, 1992,41 (3) :891 -897.
  • 7Morkve O, Learun OD. Flow cytometric measurement of P53 protein expression and DNA content in paraffin embed- ded tissue from bronchial carcinomas [ J ]. Cytometry, 1991, 12:438-441.
  • 8Zhang L, Bertucci AM, Smith KA,et al. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus [ J ]. Arthritis Rheum, 2007,56 (12) ,4132 - 4141.
  • 9Takano T, Cybulsky AV, Cupples WA, et al. Inhibition of eyelooxygenases reduces eomplenent-indueed glomerular epithelial cell injury and proteinuria in passive Heymann nephritis[J]. J Pham aeol Exp Ther, 2003, 305(1):240- 249.
  • 10Komers R, Lindsley JN, Oyama Tr, et al. Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats[J]. Clin Exp Pharmacol Physiol, 2007,34 ( 1 - 2 ) : 36 - 41.

共引文献4

同被引文献12

  • 1Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus : a systematic review [ J ]. Diabetes Care, 2007,30 (5) : 1314-1319.
  • 2Ferrara A. Increasing prevalence of gestational diabetes mellitus : a public health perspective [J].Diabetes Care,2007,30 (Suppl 2) :S141-S146.
  • 3Sobngwi E, Boudou P, Mauvais-Jarvis F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes [J]. Lancet, 2003,361 (9372) : 1861-1865.
  • 4Colomiere M, Permezel M, Lappas M. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue[J]. J Mol Endocrinol,2010,44(4):213-223.
  • 5American Diabetes Association. Standards of medical care in diabetes-2010[J]. Diabetes Care, 2010,33 Suppl 1 :SI I-$61.
  • 6Zhou YJ,Zhou H,Li Y,et al. NOD1 activation induces innate immune responses and insulin resistance in human adipocytes [ J ]. Diabetes Metab, 2012,38 (6) : 538-543.
  • 7Zhao L, Hu P,Zhou Y,et al. NOD 1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipoeytes [J]. Am J Physiol Endocrinol Metab, 2011,301 (4) : E587-E598.
  • 8Schertzer JD,Tamrakar AK, Magalhaes JG, et al. NOD1 activators link innate immunity to insulin resistance [ J ]. Diabetes, 2011,60 (9) :2206-2215.
  • 9Raspollini MR, Amunni G, Villanucci A, et al. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates[J]. Oneol Rep, 2004,11 (2) : 309-313.
  • 10Jia Z,Sun Y,Liu S,et al. COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes[J]. PLoS 0ne,2014,9(7) :e93182.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部